1. Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study. Issue 4 (19th February 2020) Authors: Stranzl, Thomas; Ipsen, Henrik; Christensen, Lars Harder; Eiwegger, Thomas; Johansen, Niels; Lund, Kaare; Andersen, Peter Sejer Journal: Allergy Issue: Volume 76:Issue 4(2021) Page Start: 1235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy". Issue 4 (11th April 2021) Authors: Stranzl, Thomas; Ipsen, Henrik; Christensen, Lars Harder; Eiwegger, Thomas; Johansen, Niels; Lund, Kaare; Andersen, Peter Sejr Journal: Allergy Issue: Volume 76:Issue 4(2021) Page Start: 1300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗